← Leaderboards
Sushil Kumar
University Of Nebraska Medical Center
$1,060,861
Attributed
$2,121,721
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $956.1K · FY2017–21$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,121,721 · 2
By mechanism
R44$1,724,644 · 1
R21$397,077 · 1
Top collaborators
- Hareesh Babu Nair3 shared
- Kusum K. Kharbanda2 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- John David Dickinson$3,503,821
- Uday B Kompella$10,057,327
- Maneesh Jain$6,905,007
- Ravi Salgia$9,622,551
- Ram I Mahato$10,713,899
Others in their field
Other Emerging Leaders on “Fibronectins”
- Ozgur Sahin · Medical University Of South Carolina$3,925,035
- Craig Patrick Ramirez · Tezcat Laboratories Llc$3,369,547
- James Craig Hartman · Mdi Therapeutics, Inc.$3,203,631
- Padmanabhan Paranji Pattabiraman · Case Western Reserve University$2,982,683
- Soula Athanasia Danopoulos · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$2,921,747
- Jonathan Kelber · California State University Northridge$2,822,143
Research focus
FibronectinsMediatingInflammationSignal PathwayPlayMouse ModelExtracellular Matrix ProteinsImmuneProgramsPreventToxic EffectStellate CellPathway InteractionsBaseDepositionExtracellular MatrixCollagenPancreasDrug Delivery SystemsDruggable TargetDiffuseCell LineDesmoplasticDose
Grant awards (5)
Targeting LIF/LIFR in pancreatic cancer$956,072
R44 · FY2021 · CA
Targeting LIF/LIFR in pancreatic cancer$614,006
R44 · FY2020 · CA
Targeting LIF/LIFR in pancreatic cancer$154,566
R44 · FY2019 · CA
Alcohol and smoking concurrently aggravate chronic pancreatitis$218,082
R21 · FY2018 · AA · contact PI
Alcohol and smoking concurrently aggravate chronic pancreatitis$178,995
R21 · FY2017 · AA · contact PI